Literature DB >> 20721647

Role of adenoidectomy in otitis media and respiratory function.

Petri S Mattila1.   

Abstract

Adenoidectomy is among the most frequent surgical procedures performed on children. The rationale for adenoidectomy is to remove a chronically infected or enlarged and obstructing adenoid. Adenoidectomies are performed on children who have recurrent or chronic otitis media with effusion, on children with chronic rhinosinusitis, and on children with nasopharyngeal obstruction causing sleep disturbances and continuous mouth breathing. Various underlying factors that lead to adenoidectomy are also associated with asthma. Asthma is associated with recurrent respiratory tract infections predisposing individuals to recurrent or chronic otitis media and chronic rhinosinusitis. Children with asthma also have an increased risk of sleep-disordered breathing that is treated with adenoidectomy in the presence of nasopharyngeal obstruction. In nonasthmatic children, adenoidectomy does not influence the development of IgE-mediated allergy, bronchial hyperreactivity, or exhaled nitric oxide concentrations, all of which are surrogate asthma markers. Adenoidectomy in selected asthmatic children may relieve comorbidities associated with asthma.

Entities:  

Mesh:

Year:  2010        PMID: 20721647     DOI: 10.1007/s11882-010-0138-7

Source DB:  PubMed          Journal:  Curr Allergy Asthma Rep        ISSN: 1529-7322            Impact factor:   4.806


  48 in total

1.  Adenoidectomy and/or tonsillectomy in childhood is not associated with atopic disease later in life.

Authors:  E S van Hattum; W A F Balemans; M M Rovers; G A Zielhuis; A G M Schilder; C K van der Ent
Journal:  Clin Exp Allergy       Date:  2006-01       Impact factor: 5.018

Review 2.  Infection associated with asplenia: risks, mechanisms, and prevention.

Authors:  B Styrt
Journal:  Am J Med       Date:  1990-05       Impact factor: 4.965

Review 3.  Adenoidectomy and tympanostomy tubes in the management of otitis media.

Authors:  Petri S Mattila
Journal:  Curr Allergy Asthma Rep       Date:  2006-07       Impact factor: 4.806

4.  Exposure to farming in early life and development of asthma and allergy: a cross-sectional survey.

Authors:  J Riedler; C Braun-Fahrländer; W Eder; M Schreuer; M Waser; S Maisch; D Carr; R Schierl; D Nowak; E von Mutius
Journal:  Lancet       Date:  2001-10-06       Impact factor: 79.321

5.  The role of antigen detection in pneumococcal carriers: a comparison between cultures and capsular antigen detection in upper respiratory tract secretions.

Authors:  W G Boersma; A Löwenberg; Y Holloway; H Kuttschrütter; J A Snijder; H Koëter
Journal:  Scand J Infect Dis       Date:  1993

6.  Respiratory syncytial virus in early life and risk of wheeze and allergy by age 13 years.

Authors:  R T Stein; D Sherrill; W J Morgan; C J Holberg; M Halonen; L M Taussig; A L Wright; F D Martinez
Journal:  Lancet       Date:  1999-08-14       Impact factor: 79.321

7.  Relationship between exhaled nitric oxide and mucosal eosinophilic inflammation in children with difficult asthma, after treatment with oral prednisolone.

Authors:  D N Payne; I M Adcock; N M Wilson; T Oates; M Scallan; A Bush
Journal:  Am J Respir Crit Care Med       Date:  2001-10-15       Impact factor: 21.405

8.  Outcome of adenotonsillectomy for severe obstructive sleep apnea in children.

Authors:  Ron B Mitchell; James Kelly
Journal:  Int J Pediatr Otorhinolaryngol       Date:  2004-11       Impact factor: 1.675

9.  Microbial exposure of rural school children, as assessed by levels of N-acetyl-muramic acid in mattress dust, and its association with respiratory health.

Authors:  Robert Theodoor van Strien; Regina Engel; Otto Holst; Albrecht Bufe; Waltraud Eder; Marco Waser; Charlotte Braun-Fahrländer; Josef Riedler; Dennis Nowak; Erika von Mutius
Journal:  J Allergy Clin Immunol       Date:  2004-05       Impact factor: 10.793

Review 10.  Host immune responses to rhinovirus: mechanisms in asthma.

Authors:  John T Kelly; William W Busse
Journal:  J Allergy Clin Immunol       Date:  2008-10       Impact factor: 10.793

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.